🧑 Human 📄 Single-arm trial 👥 36 participants ⌛ 8 weeks [Duplicate data?] · 2009 · USA (Beverly, MA)
Mirror, mirror on the wall: placebo effects that exist only in the eye of the beholder
Kelley · J Eval Clin Pract · 2009
The protocol this study used
What the authors concluded
Patients reported robust and statistically significant improvements in seven facial features at the conclusion of the 8-week treatment regimen as well as at 1-month follow-up (for all comparisons, P </= 0.003, median d = 1.14). In sharp contrast, both the treating doctor and blinded, expert raters were unable to detect any improvement whatsoever (for all comparisons, P > 0.05)." Comment: This
Devices that emit this wavelength
Matched on wavelength within 15nm, since LED bins vary by roughly that much and a tighter match would be false precision. Where we have an irradiance figure, the session length is the time needed to reach this study's dose of 0.1 J/cm² at that intensity.
DISCLOSURE — we earn commission on purchases made through our links, at no extra cost to you. Rankings come from specifications and measurements, never from commission rates.
Matching a wavelength is not the same as reproducing a trial. Session times assume the device's published irradiance is accurate at the distance it was measured, which on brand-claim figures is often optimistic. Where a device publishes both a peak and an average we use the average, and where it publishes a falloff curve we use the lowest figure, so these times run long rather than short. Clinical protocols also control for spot size, contact and skin type in ways a home device cannot.
Source
Dosimetry extracted by Vladimir Heiskanen in Photobiomodulation (PBM) research - a comprehensive database. Citation resolved against PubMed.